BBI Solutions
PublicBBI Solutions is now publicly traded
The data on this page reflects BBI Solutions's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 28, 2004
Last Round
Buyout/LBO
Aug 5, 2021
Est. Valuation at Exit
$564M
Total Funding Raised
$854.24M
Company Overview
BBI Solutions is a biotechnology company that develops and manufactures immunodiagnostic reagents and provides services for the in-vitro diagnostics, healthcare, and life science industries.
Sector
Healthcare
AI Layer
Application
Keywords
BBI Solutions Comparables
Compare BBI Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medix Biochemica | 89% | |
| CUSABIO | 86% | |
| Fortis Life Sciences | 82% |
BBI Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Aug 5, 2021 | ||||
| Buyout/LBO | Nov 19, 2015 | ||||
| M&A | Feb 1, 2008 | ||||
| IPO | Apr 28, 2004 | ||||
| Buyout/LBO | Nov 1, 2000 |
Key People
Founding team and executive leadership
BBI Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Exponent Private Equity | Buyout/LBO |
| Novo Holdings | Buyout/LBO |
| NVM Private Equity | Buyout/LBO, IPO |
BBI Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access